Pembrolizumab: Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda® Page last updated: 27 October 2023 Public Summary Document (PSD) July 2023 PBAC Meeting - (PDF 428KB) Public Summary Document (PSD) July 2023 PBAC Meeting - (Word 71KB)